• Skip to main content
  • Skip to primary sidebar

Gold Coast Health & Knowledge Precinct

Transform with us

  • Home
  • About Us
    • Strategic Plan
    • Partners
      • City of Gold Coast
      • Griffith University
      • Gold Coast Health
      • Economic Development Queensland
      • Gold Coast Private Hospital
      • Cohort
      • Southport Sharks
    • Our people
    • Precinct Office
    • Map
    • Contact Us
  • Do Business
    • Investment Incentives
  • Live & Play
    • Australia’s Gold Coast
    • Residential – Smith Collective
    • Lifestyle – Retail and Recreation
  • Work & Study
  • Projects
    • Projects Overview
    • ADaPT
    • Clinical Entrepreneurship Change Agents Program
    • NeuTex Image-guided Surgery and Robotics Training Centre
  • Research
    • Overview
      • Additive Manufacturing
      • Biotechnologies
    • Research Institutes and Centres
    • Precinct experts
    • Research Equipment & Facilities
    • Clinical Trials
    • Health and medical training and conference hub
  • News
    • Latest News
    • Newsletter
    • Media
    • Video Channel
  • 中文
    • English
    • 中文
You are here: Home / News

News

Filed Under: Uncategorised

Legacy builds in GCHKP one year on from GC2018 Commonwealth Games

Investment, Innovation, Research, Residents and Retail

One year on from the start of the Gold Coast 2018 Commonwealth Games, the GCHKP has welcomed its first residents to the new Smith Collective renter’s community, the first of the retailers have opened their doors, an exciting new co-working and innovation space COHORT will support the next generation of innovators, and Griffith University’s Advanced Design and Prototyping Technologies Institute (ADaPT) is ready to break ground later this year.

Gold Coast Private Hospital has opened its $50 million second stage expansion, while the $25 million Southport Sharks Mantra at Sharks boutique hotel is about to celebrate its first birthday. And more than 5,000 babies have been born at the Gold Coast University Hospital!

Investment opportunities for the 9.5 hectares of health and knowledge commercial land are also progressing – in addition to the flagship $80 million ADaPT development, two other sites are earmarked for development and investor interest is strong in China and Singapore. The ADaPT opportunity has also lured the Australian headquarters of global 3D printing pioneer Materialise to call the GCHKP home. We welcomed China’s Sinobioway representatives to the Precinct early this year to sign MOU’s to work with the GCHKP and Griffith University – we’re excited to see how this great opportunity for research collaboration and investment develops.

Griffith University has welcomed new Vice Chancellor, Professor Carolyn Evans, with the retirement of long-standing VC Professor Ian O’Connor. Student numbers on campus have now risen to more than 20,000, including almost 800 research students.

Griffith has risen in the global rankings to firmly cement its place in the top 2% of universities worldwide. In the 2018 Excellence in Research Australia (ERA) rankings the university doubled to 20 the number of specific fields in which researchers perform at the highest level ‘well above world standard‘, with a total of 59 fields of research in which Griffith research is now ranked at world standard or above.

New Griffith Vice Chancellor Professor Carolyn Evans

Glycomics research goes from strength to strength

Professor Mark von Itzstein had the deserving honour of carrying the Queen’s Baton for the GC2018 relay last year – his Institute for Glycomics continues to go from strength to strength, including receiving $500,000 from the Australian Government for the Malaria Vaccine project; reporting promising research on using an existing Alzheimer’s drug to combat antibiotic resistance, and work on a potential blood test for early diagnosis of ovarian cancer.

Principal Research Leader Professor Michael Good continues to be busy with his work on vaccines for Malaria and the Strep A bacteria. He’s also received $2.5 million in funding from the Heart Foundation to work on preventing strokes caused by Strep A.

Top honours for academics

Professor Huijun Zhao, Director of the#GriffithUniversity Centre for Clean Environment and Energy received major global recognition as a ‘Highly Cited’ researcher – well done on this significant honour.

Griffith Deputy Vice Chancellor (Academic) Professor Debra Henly was appointed as a board member of the National Science and Technology Advisory Council. Well done Professor Henly.

Retail is open at Smith Collective

Australia's first renters community - residents and retail move in

  • The first 200 residents have moved into the first two buildings at Smith Collective
  • Woolworths and BWS opened the retail precinct, with boutique retailers to come
  • Smith Homebase, events and community gardens up and running
The future looks bright here in the Precinct

April 4, 2019 By Kathy Kruger

Filed Under: HEALTH, INVEST

Clinical trial capacity grows through collaboration and cost advantage

Austrade's A/g Manager International Health Abdul Ekram (centre), with representatives from the GCHKP, Grififth University Clinical Trials Unit and Gold Coast Health

The Gold Coast Health and Knowledge Precinct is drawing national and international attention as a clinical trial hot spot, with a senior Austrade representative outlining the growing opportunities for the Precinct in the global clinical trial landscape.

Griffith University’s Clinical Trial Unit (CTU), together with the Gold Coast Health and Hospital Service, are fast building the GCHKP’s clinical trial capacity through a collaborative approach that brings researchers and clinicians together with industry partners to build business opportunities and best practice, supported by Australia’s cost-advantage and reputation.

Collaboration was formalised through an MOU, signed in November 2017, and continues to build with more than 100 registered trials either underway or completed.

Speaking at the inaugural ‘lunch and learn’ event, Austrade’s A/g Manager International Health, Mr Abdul Ekram, outlined the cost advantage of clinical trials in Australia, with early-phase trials 60% cheaper than they are in the United States, after tax incentives.

1,300 clinical trails are conducted in Australia each year, 63% involving industry, with the US sponsoring around 6,000 trials a year, 260 of which are conducted in Australia – there is a real growth opportunity

Professor Michael Good (left) participating in his own first-in-human clinical trial for a whole parasite Malaria vaccine with GCUH Director of Infectious Diseases Dr John Gerard

Trials range from Phase I to IV, including a second stage (1b) trial of the novel malaria vaccine PlasProtecT®, developed by the Institute for Glycomics’s Professor Michael Good AO and Senior Research Fellow Danielle Stanisic through extensive research since 2010; to a trauma study investigating whether early cooling of patients with severe traumatic brain injury produces better outcomes, led by the GCUH’s Director of Trauma and Griffith University Professor of Traumotology, Dr Martin Wullschleger.

Many trials are national and international multi-centre studies, including as part of Clinical Trials Networks such as the Australasian Kidney Trials Network, Australasian Stroke Trials Network and the National Trauma Research Institute, and conducted with leading global pharmaceutical and medtech companies, including Stryker, Medtronic, Paradigm Biopharmaceuticals and more.

Trials range across pharmaceutical studies for new and existing drugs, medical devices and surgical procedures to cancer treatment and a full range of medical specialty areas including haemotology, oncology, cardiology, endocrinology, interventional neuroradiology (led by global expert and GCUH specialist Dr Hal Rice), neurology, emergency medicine, surgery, trauma, obstetrics and gynaecology, paediatrics, allied health and complimentary medicine.

A full-list of Gold Coast Health registered trials is available here.

Dr Martin Wullschleger, GCUH Medical Director of Trauma, GU Professor of Traumology

Griffith University’s Clinical Trial Unit (CTU), located in the Griffith Health Centre on the Gold Coast campus adjacent to Gold Coast University Hospital, offers purpose-built, GCP aligned facilities for Phase I–IV clinical trials.

As a Core Research Facility of the University, the unit supports staff and collaborators to conduct a wide range of investigator initiated trials. It also provides professional trial coordination services to external clients such as the pharmaceutical, biotech, nutraceutical and complementary medicine industries, as well as Clinical Research Organisations.

The CTU has successfully conducted trials in:

  • Musculoskeletal Diseases
  • Infectious Diseases
  • Nephrology and Renal Disease
  • Endocrinology and Metabolic Disorders
  • Neurological Disorders
  • Device trials
  • Pharmacokinetic studies

A full list of current trials managed by the CTU is available here and donate or learn more about the Malaria Vaccine trial via the project website.

Gold Coast Private Hospital is also involved in a number of clinical trials in specialist areas, including cardiology, oncology and neurosurgery.

April 3, 2019 By Kathy Kruger

Filed Under: INVEST, TECHNOLOGY

Chinese partnerships to grow the bioeconomy on the Gold Coast

The SinoBioway delegation meet representatives from the GCHKP and Griffith University

The Gold Coast Health and Knowledge Precinct (GCHKP) and Griffith University have signed complimentary memorandums of understanding (MOU’s) with a major Chinese biotechnology company associated with Beijing University, paving the way for significant research jobs and opportunities.

SinoBioway is a Chinese leader in developing biology-based technologies for medical, environmental and manufacturing applications and will set up an Australian landing company based in the GCHKP as it explores research projects with Griffith experts, and eventually a permanent presence in the Precinct.

The MOU with Griffith University is focused on stem cell research, identifying opportunities for project collaboration and joint research funding applications, promotion of Griffith capabilities and technologies in China and potential for clinical trials in China.

The Griffith MOU specifies a relationship with SinioBioway subsidiary Bantang National Gene Centre, based with the parent company in the Chaohu Economic Development Zone in Hefei, Anhui Province, while also allowing scope for broader opportunities across the company’s diverse operations.

GCHKP Project Director Di Dixon with Griffith Senior Deputy Vice Chancellor Professor Ned Pankhurst, SinoBioway Chairman Li Yunming and Griffith Enterprise Deputy Director Dr Jens Tampe

 Stem Cell Research to be focus for collaboration

The MOU signings follow a high level visit to the GCHKP by representatives of SinoBioway, including Chairman Li Yunming, that included presentations on the Precinct, a visit to the Gold Coast University Hospital and viewing of investment sites, and presentations and a laboratory tour to showcase Griffith’s research capabilities.

The Precinct’s innovation and co-working hub, Cohort, has been identified as a potential landing space for SinoBioway’s initial operations in Australia, providing ready access to researchers working on stem-cell based spinal injury repair at the Clem Jones Centre for Neurobiology and Stem Cell Research, Menzies Health Institute Queensland.

Opportunities have also been identified to utilised Griffith’s unique Neurobank resource, and the delegation was also given a presentation on an exciting Medtech funded project that is developing artificial wrist ligament, led by GCUH orthopaedic surgeon and Griffith Professor Randy Bindra and leading biomechanical engineer Professor David Lloyd.

Professor Randy Bindra (right) trains surgeons from India in the latest wrist surgery techniques

Environmental technologies and advanced manufacturing opportunities to be explored

Professor Huijun Zhao, Director, Centre for Clean Environment and Energy, Deputy Director Griffith Environmental Futures Institute
Professor Huijun Zhao, Director, Centre for Clean Environment and Energy, Deputy Director Griffith Environmental Futures Institute

The MOU may also allow collaboration to be explored with the Centre for Clean Environment and Energy, led by Professor Huijun Zhao, who holds distinguished membership of the Chinese Government’s One Thousand Foreign Experts Program of “State Specially Recruited Experts”, and is also Director of Centre for Environment and Energy nanomaterials, at the Institute of Solid State Physics, Chinese Academy of Sciences (CAS) in Hefei.

As one of China’s largest bioengineering pharmaceutical firms, Sinobioway Group harnesses the growing power of biotechnology to address society’s biggest challenges. Since its founding in 1992, it has been devoted to the development of a thriving industry within a bioeconomic system, a concept developed by Sinobioway’s founder Aihua Pan.

Encompassing more than 50 subsidiaries, Sinobioway’s businesses span biomedicine, bioagriculture, bioenergy, bioenvironment, bioservice, biomanufacturing, and biointelligence, with more than a dozen locations across China.

The GCHKP and Griffith are also working closely with the Australian Zhongguancun Private Equity & Venture Capital Association to progress opportunities – Zhongguancun is a technology hub in Beijing that has been described as China’s silicon valley.

GCHKP Project Director Di Dixon with Senior Deputy Vice Chancellor Professor Ned Pankhurst, Kerry Wang, Secretary General of the Australia Zhongguancun Private Equity & Venture Capital Association and Griffith Enterprise Deputy Director Dr Jens Tampe

March 13, 2019 By Kathy Kruger

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Go to Next Page »

Primary Sidebar

Recent Posts

  • From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort
  • A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast
  • Clinician Entrepreneurship Program wraps as a big success
  • 2025 International Women’s Day
  • International Women’s Day event 2025
  • Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research
  • INVEST-FEST accelerates founder funding
  • Student innovation incubator set to launch in 2025
  • World-first clinical trial for treating spinal cord injury
  • Australian-designed Total Artificial Heart amongst The Australian’s Top 100

Archives

  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • May 2024
  • April 2024
  • January 2024
  • December 2023
  • October 2023
  • September 2023
  • August 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • October 2022
  • August 2022
  • July 2022
  • May 2022
  • March 2022
  • February 2022
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • March 2020
  • February 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018

Subscribe to our newsletter and we’ll update you on all that’s new in our Precinct.

Latest News

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort image

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort

Read More >

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast image

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast

Read More >

Clinician Entrepreneurship Program wraps as a big success image

Clinician Entrepreneurship Program wraps as a big success

Read More >

2025 International Women's Day image

2025 International Women's Day

Read More >

International Women's Day event 2025 image

International Women's Day event 2025

Read More >

Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research image

Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research

Read More >

Before Footer

Search

Asia-Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health & Knowledge Precinct (GCHKP) is a unique global business location for high-tech industry development, research collaboration and jobs of the future.

  • Home
  • About Us
  • Precinct Map
  • News
  • Do Business
  • Work & Study
  • Partners
  • Projects
  • Research
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Subscribe
  • Facebook
  • LinkedIn
  • YouTube

© 2025 Gold Coast Health and Knowledge Precinct. All rights reserved.

Designed and Developed by Stead Lane